期刊文献+

不同剂量铁对小鼠肝脏损伤作用的实验研究 被引量:8

Study of the Liver Damage Effect of Different Dosage of Iron Dextran
暂未订购
导出
摘要 目的探讨不同剂量的右旋糖酐铁对小鼠肝脏抗氧化水平和病理损伤的影响。方法将雌雄各半的昆明小鼠随机分为4组,以不同浓度的右旋糖酐铁隔日腹腔注射(IP),注射6周后,测定肝组织中丙二醛(MDA)的含量、超氧化物歧化酶(SOD)以及谷胱甘肽过氧化物酶(GSH-PX)的活性,测定血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(AKP)、酸性磷酸酶(ACP)活性,并做肝脏病理组织学检查。结果与正常对照组相比,肝组织中MDA的含量较对照组明显升高(P<0.001),SOD和GSH-PX的活性则明显下降(P<0.001)。血清ALT、AST活性较对照组明显升高(P<0.001),且有剂量效应关系;而血清AKP、ACP活性较对照组则无显著性差异(P>0.05)。病理组织学检查,经铁染色后镜下可见低剂量组有少量铁均匀分布,中高剂量组则有大量铁存在。结论过量的铁可对肝脏造成严重的损害,且呈剂量依赖性,其机制可能与铁在肝脏内代谢释放出铁离子,游离的铁离子介导脂质过氧化而造成肝脏损害有关。 Objective To study the level of mice liver antioxygen and the degree of mice fiver pathologiccal damage through intraperitoneal injection of different dose of iron dextran in mice. Method Male and female mice were randomly divided into four groups and were ntraperitoneally injected with different doses of iron dextran every the other day, for six weeks. The levels of MDA, SOD and GSH-PX in the liver and the levels of ALT, AST, AKP and ACP in the blood-serums were measured. Pathohistology analysis of the liver was also performed. Result Comparing with the normal group, the MDA level in the liver was significantly increased (P〈0.001), and the levels of SOD and GSH-PX were dramatically decreased (P〈 0.001 ). There is no significant difference the levels of AKP and ACP between the normal group and the treated group. The pathohistology examination result showed that iron scatter in the low-dose treated group was more than that in the high-dose group. Conclusion Excess iron cause severe damage of the liver in a dose dependent manner. The mechanism may be the ferrous which release from liver cause lipid peroxidation.
出处 《热带医学杂志》 CAS 2007年第2期129-132,共4页 Journal of Tropical Medicine
关键词 肝损伤 脂质过氧化 iron liver damage lipid peroxidation
  • 相关文献

参考文献20

  • 1KONTOGHIORGHES GJ.Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone.Implications in the treatment of thalassemia,anemia of chronic disease,cancer and other conditions[J].Hemoglobin,2006,30(2):183-200.
  • 2BARTFAY WJ,HOU D,LEHOTAY DC,et al.Cytotoxic aldehyde generation in heart following acute iron-loading[J].J Trace Ele Med Biol,2000,14(1):14-20.
  • 3BARTFAY WJ,SHER GD,LEHOTAY DC,et al.Erythropoiesis:Comparison of cytotoxie aldehyde in betathalassemia patients chelated with deferoxamine or defefiprone (L1) versus no chelation[J].Hematology,1999,4(1):67-76.
  • 4CORRADINI E,FERRERA F,PIETRANGELO A.Iron and the liver[J].Pediatr Endocrinol Rev,2004,2(Suppl 2):245-248.
  • 5FRANCHINI M,VENERI D.Hereditary hemochromatosis[J].Hematology,2005,10(2):145-149.
  • 6FEDER JN,GNIRKE A,THOMAS W.A novel MHC class Ⅰ-like gene is mutated in patients with hereditary haemechromatosis[J].Nat Genet,1996,13(4):399-408.
  • 7LIU P,OLIVIERI N.Iron-overload cardiomyopathies:new insights into an old disease[J].Cardiovascular Drugs and Ther,1994,8(1):101-110.
  • 8WHEELER CJ,KOWDLEY KV.Hereditary hemochromatosis:a review of the genetics,mechanism,diagnosis,and treatment of iron overload[J].Compr Ther,2006,32(1):10-16.
  • 9张传海.人体铁过多与心脏损害[J].临床荟萃,1995,10(5):193-194. 被引量:10
  • 10YURKOVA I,KISEL M,ARNHOLD J,et al.Iron-mediated free-radical formation of signaling lipids in a model system[J].Chem Phys Lipids,2005,137(1-2):29-37.

二级参考文献27

  • 1郭茂林,杨频.金属有机配合物对DNA的断链作用[J].高等学校化学学报,1995,16(7):1014-1015. 被引量:8
  • 2BONKOVSKY HL. Iron and liver[J]. The American Journal of the Med ical Sciences, 1991, 301: 32-43.
  • 3THORSTENSEN K, ROMSLO I. Uptake of iron from transferrin by isolat ed rat hepatocytes. A redox-mediated plasma membrane process[J]. J Biol Chem, 1988, 263: 8844-8850.
  • 4SMITH A, MORGEN WJ. Haem transport to the liver by haemopexin. Rec eptor-mediated uptake with recycling of the protein[J]. Biochem J, 1979, 182: 47-54.
  • 5WRIGHT TL, FITZ JG, WEISIGER RA. Non-transferrin-bound iron upta ke by rat liver. Role of membrane potential difference[J]. Bio Chem, 1988, 263 : 1842-1847.
  • 6HANZLIK RP, SOINE WH, MACINAV C. Enzymatic hydroxylation of fer rocene[J]. J Am Chem Soc, 1978, 100: 1290-1291.
  • 7VALERIO LG.PETERSEN DR. Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice : cellular, biochemical, and molecular aspects[J]. Exp Mol Pathol,2000,68(1):1- 12.
  • 8DULLMANN J, WULFHEKEL U, NIELSEN P, et al. Iron over load of the liver by trimethylhexanoylferrocene in rats[J]. Anatomica, 1992, 1 43: 96-108.
  • 9LONGAEVILLE A, CRICHTON RT. An animal model of iron overload and i ts application to study hepatic ferritin iron mobilzation by chelators[J]. Bio chemical Pharmacology, 1986, 35: 3666-3678.
  • 10TJALKENS RB, VALERIO LG. Association of glutathione s-transferra se isozyme-specific induction and lipid peroxidation in two inbred strains of m ice subjected to chronic dietary iron overload[J]. Toxicology and Applied Phar macology, 1998, 151: 174-181.

共引文献18

同被引文献79

引证文献8

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部